Post-doctoral Training Program in Cancer Metabolism and Tumor-host Interactions

癌症代谢和肿瘤宿主相互作用博士后培训项目

• 批准号: 10596510
• 负责人: Yibin Kang
• 金额: $ 29.89万
• 依托单位: RUTGERS BIOMEDICAL AND HEALTH SCIENCES
• 依托单位国家: 美国
• 财政年份: 2021
• 资助国家: 美国
• 起止时间: 2021-04-01 至 2026-03-31
• 项目状态: 未结题
• 来源: https://reporter.nih.gov/project-details/10596510
• 关键词: Training Programs; host neoplasm interaction; post-doctoral training; tumor metabolism

Rutgers Cancer Institute of New Jersey (RCINJ) provides an outstanding environment for training in basic, clinical, behavioral or population-based cancer research and brings together an exceptional group of investigators organized in multi-disciplinary research teams focusing on a broad spectrum of cancer research. The Cancer Metabolism and Growth (CMG) Program, at RCINJ has robust research strengths bolstered by strong collaboration between researchers at Rutgers and our formal consortium partner Princeton University. The proposed program leverages these unique research strengths and resources of RCINJ to provide training in translational research in Cancer Metabolism and Growth and Tumor Host Interactions. The primary goal of this T32 training program is to provide postdoctoral candidates with the highest quality training and research experience so that they are competitive in developing research careers in academia, government, and the private sector. To achieve this goal, trainees will engage in mentored cancer research, co-curricular and professional career development activities for two years. Program candidates are Ph.D. recipients who wish to develop careers in cancer research. The program will recruit a cohort of 2 new trainees each year from year 1-5. Thus, the program will have 2 trainees in year 1 and 4 trainees in year 2 through 5 of the training grant. High achieving post-doctoral fellows (evidenced by research productivity in the form of number of publications, fellowship awards, presentations etc.), may be supported for an additional third year of training through institutional funds. Faculty members with active, well-funded research programs and extensive mentoring experience will support program trainees. All of the faculty mentors chosen for this program have significant R01-level peer reviewed funding in tumor metabolism and host interactions focused research. Experienced leadership team with track-record of research productivity and mentoring will ensure successful implementation of the program. Both formative and summative evaluation will be integral parts of the proposed program. We will annually track the educational and professional activities of trainees for at least 10 years after completing research training. We will disseminate results from the comprehensive evaluation on the program website. Additional dissemination will occur through articles published in peer-reviewed journals and through presentations at regional and national conferences, by program staff as well as participants. Our program benefits from the multi-disciplinary research environment and robust educational resources available at RCINJ (the state's only NCI designated Comprehensive Cancer Center) as well as the consortium relationship with Princeton University. 19

新泽西州罗格斯癌症研究所（RCINJ）为基础培训提供了一个杰出的环境 临床，行为或基于人群的癌症研究，并汇集了一组 在多种癌症研究的多学科研究团队中组织的研究人员。 RCINJ的癌症代谢和生长（CMG）计划具有强大的研究优势。 罗格斯的研究人员与我们的正式财团合作伙伴普林斯顿大学之间的强有力合作。 拟议的计划利用RCINJ的这些独特的研究优势和资源来提供培训 在癌症代谢和生长和肿瘤宿主相互作用的转化研究中。主要 该T32培训计划的目标是为博士后候选人提供最高质量的培训和 研究经验使他们在发展学术界，政府，政府， 和私营部门。为了实现这一目标，学员将进行指导的癌症研究 和职业职业发展活动两年。课程候选人是博士学位。接受者谁 希望发展癌症研究的职业。该计划将每年从 1 - 5年。因此，该计划将在1年级有2名学员，在培训的第2年至5年级中将有4名学员 授予。高成就的博士后研究员（通过研究生产力以数量的形式证明 出版物，奖学金奖，演讲等）可以为额外的第三年培训提供支持 通过机构资金。拥有活跃，资金充足的研究计划和广泛的教职员工 指导经验将支持计划受训者。为此计划选择的所有教师都有 大量的R01级同行审查了肿瘤代谢和宿主相互作用的重点研究的资金。 经验丰富的领导团队具有研究生产力和指导的田径记录将确保成功 程序的实施。形成性和总结性评估都将是提议的组成部分 程序。我们每年将在至少10年中跟踪学员的教育和专业活动 完成研究培训后。我们将通过对有关的全面评估进行传播结果 程序网站。通过在同行评审期刊上发表的文章以及 通过计划人员和参与者在区域和国家会议上的演讲。我们的 计划从多学科研究环境和可用的强大教育资源中受益 在RCINJ（该州唯一的NCI指定综合癌症中心）以及财团 与普林斯顿大学的关系。 19